Main Analytical Methods for the Viability Assessment of Mesenchymal Stem Cells for Use as Cellular Medicines

被引：4

作者：

Galocha-Leon, Cristina ^{[1
]}

Clares-Naveros, Beatriz ^{[1
]}

Galvez-Martin, Patricia ^{[1
,2
]}

机构：

[1] Univ Granada, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-18071 Granada, Spain

[2] Bioiberica SAU, Adv Therapies Area, E-08029 Barcelona, Spain

来源：

CURRENT PHARMACEUTICAL ANALYSIS | 2018年 / 14卷 / 05期

关键词：

Mesenchymal stem cells; cell therapy; cell viability; cell count; analytical methods; quality control assays; FLUORESCENT-PROTEIN BIOSENSORS; TRYPAN BLUE; CYTOTOXICITY; GROWTH; SYSTEM; ASSAYS; TOOLS;

D O I：

10.2174/1573412913666170613090734

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background: Mesenchymal Stem Cells (MSCs) are multipotent stem cells with therapeutic potential in advanced therapies and regenerative medicine. Currently, MSCs are being widely studied as cellular medicine. In the design and development of medicines with cells, the study of viability is an important quality control requirement. Objective: Description of the main analytical techniques to study the MSCs viability as cellular medicine. Results: The cellular medicine must contain viable cells, for its use in vivo the cell viability must be at least greater or equal to 80%. Therefore, the study of cell viability of MSCs during its ex vivo expansion and its final formulation is a prerequisite before being administered. Conclusion: In this review the main analytical techniques based on studies of the cell membrane integrity, morphological assays and fluorescence biosensors are described. All of them are approved for use in quality control programs for clinical use of MSCs.

引用

页码：427 / 436

页数：10

共 50 条

[21] Cellular mechanisms of emerging applications of mesenchymal stem cells
Mok, Pooi-Ling
Leong, Chooi-Fun
Cheong, Soon-Keng
MALAYSIAN JOURNAL OF PATHOLOGY, 2013, 35 (01) : 17 - 32
[22] Controlling Cellular Biomechanics of Human Mesenchymal Stem Cells
Titushkin, Igor A.
Cho, Michael R.
2009 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-20, 2009, : 2090 - 2093
[23] CELLULAR AGING AND SENESCENCE CHARACTERISTICS OF MESENCHYMAL STEM CELLS
Lee, J.
Byeon, J.
Park, M.
Gu, N.
Cho, I.
Cha, S.
CYTOTHERAPY, 2017, 19 (05) : S107 - S107
[24] REAL-TIME QUALITY CONTROL AND FUNCTIONAL ASSESSMENT OF MESENCHYMAL STEM CELLS FOR CELLULAR THERAPIES
Abassi, Y. A.
CYTOTHERAPY, 2019, 21 (05) : E11 - E12
[25] Haematopoietic stem cells and mesenchymal stem cells as tools for present and future cellular therapies
Kindler, Vincent
Suva, Domizio
Soulas, Caroline
Chapuis, Bernard
SWISS MEDICAL WEEKLY, 2006, 136 (21-22) : 333 - 337
[26] Assessment of immunosuppression exerted by mesenchymal stem cells
Jin, N.
Malcherek, G.
Wuchter, P.
Diehlmann, A.
Schmitt, A.
Ho, A. D.
Schmitt, M.
BONE MARROW TRANSPLANTATION, 2013, 48 : S175 - S175
[27] Effect of mesenchymal stem cells on the viability, proliferation and differentiation of B lymphocytes
Tabera, Soraya
Perez-Simon, Jose A.
Diez-Campelo, Maria
Sanchez-Abarca, Luis I.
Blanco, Belen
Benito, Ana
Ocio, Enrique
Sanchez-Guijo, Fermin M.
Canizo, Consuelo
San Miguel, J. F.
BLOOD, 2007, 110 (11) : 38B - 38B
[28] Erratum to: Viability of equine mesenchymal stem cells during transport and implantation
Elaine R. Garvican
Sandra Cree
Lydia Bull
Roger K. W. Smith
Jayesh Dudhia
Stem Cell Research & Therapy, 7
[29] Evaluation of the effects of Cimicifugae Rhizoma on the morphology and viability of mesenchymal stem cells
Jeong, Su-Hyeon
Lee, Ji-Eun
Kim, Bo-Bae
Ko, Youngkyung
Park, Jun-Beom
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 629 - 634
[30] VALIDATION OF ANALYTICAL METHODS FOR IN-PROCESS CHARACTERIZATION OF HUMAN MESENCHYMAL STEM CELLS USED FOR CLINICAL STUDIES
Theys, N.
Thys, S.
Vandermeers, F.
CYTOTHERAPY, 2014, 16 (04) : S93 - S93

← 1 2 3 4 5 →